Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Shell Asset Management Co.

Shell Asset Management Co. reduced its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 3.4% in the 1st quarter, HoldingsChannel.com reports. The fund owned 6,781 shares of the company’s stock after selling 237 shares during the quarter. Shell Asset Management Co.’s holdings in Prestige Consumer Healthcare were worth $492,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Covestor Ltd grew its position in shares of Prestige Consumer Healthcare by 21.6% during the first quarter. Covestor Ltd now owns 834 shares of the company’s stock worth $61,000 after buying an additional 148 shares in the last quarter. Pacer Advisors Inc. boosted its holdings in Prestige Consumer Healthcare by 85.7% in the fourth quarter. Pacer Advisors Inc. now owns 442 shares of the company’s stock valued at $27,000 after purchasing an additional 204 shares in the last quarter. Parallel Advisors LLC boosted its holdings in Prestige Consumer Healthcare by 42.5% in the fourth quarter. Parallel Advisors LLC now owns 714 shares of the company’s stock valued at $44,000 after purchasing an additional 213 shares in the last quarter. M&T Bank Corp boosted its holdings in Prestige Consumer Healthcare by 7.5% in the fourth quarter. M&T Bank Corp now owns 4,139 shares of the company’s stock valued at $253,000 after purchasing an additional 289 shares in the last quarter. Finally, Swiss National Bank boosted its holdings in Prestige Consumer Healthcare by 0.3% in the first quarter. Swiss National Bank now owns 97,900 shares of the company’s stock valued at $7,104,000 after purchasing an additional 300 shares in the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently issued reports on PBH. DA Davidson raised Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and upped their price target for the company from $65.00 to $93.00 in a report on Friday, June 21st. Canaccord Genuity Group reiterated a “buy” rating and issued a $80.00 price objective on shares of Prestige Consumer Healthcare in a research note on Tuesday, May 21st. Finally, StockNews.com cut Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, May 21st. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $98.25.

Prestige Consumer Healthcare Price Performance

NYSE:PBH traded up $0.54 during trading hours on Friday, hitting $70.94. The company’s stock had a trading volume of 23,416 shares, compared to its average volume of 245,595. The business’s 50-day moving average is $67.08 and its two-hundred day moving average is $67.78. The company has a market capitalization of $3.52 billion, a PE ratio of 16.88, a PEG ratio of 1.99 and a beta of 0.49. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 3.20. Prestige Consumer Healthcare Inc. has a 52-week low of $56.34 and a 52-week high of $75.31.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Tuesday, May 14th. The company reported $1.02 earnings per share for the quarter, missing analysts’ consensus estimates of $1.14 by ($0.12). Prestige Consumer Healthcare had a net margin of 18.60% and a return on equity of 13.48%. The firm had revenue of $277.00 million during the quarter, compared to analysts’ expectations of $287.42 million. During the same quarter in the prior year, the business earned $1.07 EPS. The company’s quarterly revenue was down 3.1% compared to the same quarter last year. As a group, research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.